Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Smith DA. Review: In dyslipidemia or atherosclerotic CVD, alirocumab and evolocumab vs control each reduce MI and stroke. Ann Intern Med 2019;171:JC56.
PMID: 31739339


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016